Emergent BioSolutions (EBS) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.00 --0%
Revenue Growth %: +32.0%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +32.0%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $120.45 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- CRH agrees to buy Arcosa in $8.5B all-cash deal
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
